Psychedelics 2020’s top 5 advancements in psychedelics With major research, legal reform, and more than 20 firms going public, it was major year for the re-emerging field Jared GnamDecember 30, 2020
International A record 3,627 cannabis studies conducted in 2020 From CBD drivers to stoner rats, legal reform continues to push weed research to an all-time high Jared GnamDecember 28, 2020
Extraction Canopy’s GW Pharma lawsuit could be trouble for US extractors Canopy has a fair shot at winning its suit against GW, but the case might not have a widespread effect on US pot extractors,... Jared GnamDecember 24, 2020
Industry update MagicMed attracts investors to advance library of psychedelic derivatives After raising $8.1M, the Calgary company filed 12 patents and launched a candidate selection program for novel psychedelic mental health treatments Jared GnamDecember 23, 2020
Canada Health Canada delivers cannabis data dump for the holidays The federal agency reports a rise in national pot use and medical cannabis registrations in 2020, as well as new enforcement data Jared GnamDecember 22, 2020
Industry update Canopy Growth inks $297M deal to give up stake in Canopy Rivers The Canadian weed giant is cutting ties with its venture capital firm that will have the freedom to focus on the U.S. market Jared GnamDecember 21, 2020
Industry update Unifor and Aleafia Health team up in push for medical cannabis coverage With 315,000 workers, Canada's largest private union is set to recommend insurance coverage in collective bargaining agreements Jared GnamDecember 18, 2020
Industry update Canadian cannabis sales climb to $270M in October Ontario led all provinces for the fifth straight month with sales growing 7.6% in October to $83.9 million Jared GnamDecember 18, 2020
Canada Remove OCS advantages to increase Ontario’s legal market share, pot shops say While the OCS says it's fighting the illicit market in its Q2 report, a Toronto retailer offers other ways to make Ontario's legal pot... Jared GnamDecember 18, 2020
Industry update Tilray and Aphria unveil merger plan to create world’s biggest weed firm But the $5B all-stock deal raised doubts if two bloated producers could combine to become anything better Jared GnamDecember 16, 2020